Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 108.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 148.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.69m
  • Volume: 81
  • Market Cap: £115.76m
  • RiskGrade: 187

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
4.29% above the market average4.29% above the market average4.29% above the market average4.29% above the market average4.29% above the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average
1yr Revenue Growth
5.94% below the market average5.94% below the market average5.94% below the market average5.94% below the market average5.94% below the market average
11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
39.08% below the market average39.08% below the market average39.08% below the market average39.08% below the market average39.08% below the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
1yr DPS Growth
41.75% below the market average41.75% below the market average41.75% below the market average41.75% below the market average41.75% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
52.6% below the market average52.6% below the market average52.6% below the market average52.6% below the market average52.6% below the market average
76.92% below the sector average76.92% below the sector average76.92% below the sector average76.92% below the sector average76.92% below the sector average
Price Book Ratio
25.09% below the market average25.09% below the market average25.09% below the market average25.09% below the market average25.09% below the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
76.61% below the market average76.61% below the market average76.61% below the market average76.61% below the market average76.61% below the market average
65% below the sector average65% below the sector average65% below the sector average65% below the sector average65% below the sector average
Price Chg 3m
21.59% below the market average21.59% below the market average21.59% below the market average21.59% below the market average21.59% below the market average
70% below the sector average70% below the sector average70% below the sector average70% below the sector average70% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
62.88% below the market average62.88% below the market average62.88% below the market average62.88% below the market average62.88% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
Momentum 20
76.86% below the market average76.86% below the market average76.86% below the market average76.86% below the market average76.86% below the market average
74.36% below the sector average74.36% below the sector average74.36% below the sector average74.36% below the sector average74.36% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
21.41% below the market average21.41% below the market average21.41% below the market average21.41% below the market average21.41% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
ROCE
55.54% above the market average55.54% above the market average55.54% above the market average55.54% above the market average55.54% above the market average
10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
24.40% above the market average24.40% above the market average24.40% above the market average24.40% above the market average24.40% above the market average
56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average
Forecast EPS
27.24% below the market average27.24% below the market average27.24% below the market average27.24% below the market average27.24% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
41.78% above the market average41.78% above the market average41.78% above the market average41.78% above the market average41.78% above the market average
57.58% above the sector average57.58% above the sector average57.58% above the sector average57.58% above the sector average57.58% above the sector average
Operating Profit Loss
19.53% above the market average19.53% above the market average19.53% above the market average19.53% above the market average19.53% above the market average
35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
25.61% above the market average25.61% above the market average25.61% above the market average25.61% above the market average25.61% above the market average
35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average
Cash
1.16% below the market average1.16% below the market average1.16% below the market average1.16% below the market average1.16% below the market average
5.56% above the sector average5.56% above the sector average5.56% above the sector average5.56% above the sector average5.56% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
9.65% above the market average9.65% above the market average9.65% above the market average9.65% above the market average9.65% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Buys 1y
6.89% below the market average6.89% below the market average6.89% below the market average6.89% below the market average6.89% below the market average
13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral
38.86% above the market average38.86% above the market average38.86% above the market average38.86% above the market average38.86% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 108.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 148.50
52 Week Low 101.00
Volume 81
Shares Issued 106.69m
Market Cap £115.76m
RiskGrade 187

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.83% below the market average38.83% below the market average38.83% below the market average38.83% below the market average38.83% below the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Price Trend
3.85% below the market average3.85% below the market average3.85% below the market average3.85% below the market average3.85% below the market average
43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average
Income
11.85% above the market average11.85% above the market average11.85% above the market average11.85% above the market average11.85% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
37.6% below the market average37.6% below the market average37.6% below the market average37.6% below the market average37.6% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  2nd Interim Interim
Ex-Div 23-Apr-20 03-Oct-19
Paid 22-May-20 01-Nov-19
Amount 1.00p 1.15p

Trades for 01-Jun-2020

Time Volume / Share Price
09:50 81 @ 110.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page